Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.78 +0.12 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

Unicycive Therapeutics (UNCY) Notes Payables (2020 - 2021)

Updated

Unicycive Therapeutics (UNCY) posted Notes Payables of $3.2 million for Q2 2021.

Analysis

Unicycive Therapeutics (UNCY) Notes Payables (2020 - 2021) Analysis & Trends

At the end of FY2020, Unicycive Therapeutics' Notes Payables came in at $1.53 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Unicycive Therapeutics 101.95 Mn -98.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 3.20 Mn
Dec 31, 2020 1.53 Mn
API Access

Unicycive Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=UNCY&period=max&api_key=YOUR_API_KEY